Antares Pharma, Inc., a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries Ltd. today announced the filing of a Supplemental New Drug Application (sNDA) in order to add “needle-free injection” to the product drug label.
The details can be read here.
No comments:
Post a Comment